BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

968 related articles for article (PubMed ID: 19450842)

  • 1. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
    Hedgepeth RC; Labo J; Zhang L; Wood DP
    J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical interpretation of the Expanded Prostate Cancer Index Composite-Short Form sexual summary score.
    Wheat JC; Hedgepeth RC; He C; Zhang L; Wood DP
    J Urol; 2009 Dec; 182(6):2844-9. PubMed ID: 19837418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age stratified functional outcomes after laparoscopic radical prostatectomy.
    Rogers CG; Su LM; Link RE; Sullivan W; Wagner A; Pavlovich CP
    J Urol; 2006 Dec; 176(6 Pt 1):2448-52. PubMed ID: 17085126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of prostate size on urinary quality of life indexes following laparoscopic radical prostatectomy.
    Levinson AW; Bagga HS; Pavlovich CP; Mettee LZ; Ward NT; Link RE; Su LM
    J Urol; 2008 May; 179(5):1818-22. PubMed ID: 18353375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer.
    Namiki S; Takegami M; Kakehi Y; Suzukamo Y; Fukuhara S; Arai Y
    J Urol; 2007 Aug; 178(2):473-7; discussion 477. PubMed ID: 17561164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
    Glickman L; Godoy G; Lepor H
    J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.
    Penson DF; McLerran D; Feng Z; Li L; Albertsen PC; Gilliland FD; Hamilton A; Hoffman RM; Stephenson RA; Potosky AL; Stanford JL
    J Urol; 2005 May; 173(5):1701-5. PubMed ID: 15821561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: a study of comparative effectiveness based upon validated quality of life outcomes.
    Willis DL; Gonzalgo ML; Brotzman M; Feng Z; Trock B; Su LM
    BJU Int; 2012 Mar; 109(6):898-905. PubMed ID: 21933328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument.
    Hollenbeck BK; Dunn RL; Wei JT; Montie JE; Sanda MG
    J Urol; 2003 Apr; 169(4):1453-7. PubMed ID: 12629382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robotic radical prostatectomy for elderly patients: probability of achieving continence and potency 1 year after surgery.
    Shikanov S; Desai V; Razmaria A; Zagaja GP; Shalhav AL
    J Urol; 2010 May; 183(5):1803-7. PubMed ID: 20299041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administrative data sets are inaccurate for assessing functional outcomes after radical prostatectomy.
    Tollefson MK; Gettman MT; Karnes RJ; Frank I
    J Urol; 2011 May; 185(5):1686-90. PubMed ID: 21419458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy.
    Kübler HR; Tseng TY; Sun L; Vieweg J; Harris MJ; Dahm P
    J Urol; 2007 Aug; 178(2):488-92; discussion 492. PubMed ID: 17561133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life outcomes after brachytherapy for early stage prostate cancer.
    Brandeis JM; Litwin MS; Burnison CM; Reiter RE
    J Urol; 2000 Mar; 163(3):851-7. PubMed ID: 10687991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy.
    Gralnek D; Wessells H; Cui H; Dalkin BL
    J Urol; 2000 Apr; 163(4):1166-9; discussion 1169-70. PubMed ID: 10737488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.